Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia

BACKGROUND: In clinical practice, clinicians often need to switch antipsychotic medications in patients with schizophrenia to optimize treatment outcomes. Here, we describe the safety and tolerability of switching existing antipsychotic treatments to asenapine or olanzapine monotherapy using various...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazorla, Pilar, Mackle, Mary, Zhao, Jun, Ha, Xianwei, Szegedi, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383320/
https://www.ncbi.nlm.nih.gov/pubmed/22745558
http://dx.doi.org/10.2147/NDT.S29891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383320/
https://www.ncbi.nlm.nih.gov/pubmed/22745558
http://dx.doi.org/10.2147/NDT.S29891

Ejemplares similares